NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $24.14 +0.05 (+0.21%) Closing price 03:59 PM EasternExtended Trading$24.16 +0.02 (+0.06%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Guardian Pharmacy Services Stock (NYSE:GRDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GRDN alerts:Sign Up Key Stats Today's Range$23.73▼$24.6450-Day Range$18.37▼$24.1352-Week Range$14.16▼$25.74Volume45,382 shsAverage Volume151,193 shsMarket Capitalization$1.53 billionP/E RatioN/ADividend YieldN/APrice Target$22.33Consensus RatingBuy Company OverviewGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.Read More… Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageGuardian Pharmacy Services has only been the subject of 1 research reports in the past 90 days.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-3.45% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to decrease by -3.45% in the coming year, from $0.87 to $0.84 per share.Read more about Guardian Pharmacy Services' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GRDN. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GRDN. News and Social Media2.9 / 5News Sentiment1.20 News SentimentGuardian Pharmacy Services has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.MarketBeat Follows4 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Email Address GRDN Stock News HeadlinesGuardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care ...April 14, 2025 | gurufocus.comGuardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West VirginiaApril 14, 2025 | businesswire.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 25, 2025 | Porter & Company (Ad)Guardian Pharmacy Services Adds Naples Pharmacy to Further Strengthen Long-Term Care Services in Southwest FloridaApril 8, 2025 | businesswire.comGUARDIAN PHARMACY SERVICES Earnings Results: $GRDN Reports Quarterly EarningsMarch 28, 2025 | nasdaq.comGuardian Pharmacy Services Full Year 2024 Earnings: EPS Misses ExpectationsMarch 28, 2025 | finance.yahoo.comTruist Financial Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)March 27, 2025 | markets.businessinsider.comGuardian Pharmacy reports Q4 EPS 19c, consensus 22cMarch 27, 2025 | markets.businessinsider.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $20.26 on January 1st, 2025. Since then, GRDN shares have increased by 20.5% and is now trading at $24.4050. View the best growth stocks for 2025 here. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) released its earnings results on Tuesday, November, 12th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $0.19 by $2.19. The firm had revenue of $314.39 million for the quarter, compared to analysts' expectations of $303.21 million. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO. When did Guardian Pharmacy Services' lock-up period expire? Guardian Pharmacy Services' lock-up period expired on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period. Who are Guardian Pharmacy Services' major shareholders? Top institutional investors of Guardian Pharmacy Services include Allspring Global Investments Holdings LLC (0.45%), Peregrine Capital Management LLC (0.28%) and GAMMA Investing LLC. Insiders that own company stock include Thomas J Salentine Jr and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings11/12/2024Today4/25/2025Next Earnings (Estimated)6/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Drug stores & proprietary stores Sub-IndustryRetail Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,200Year FoundedN/APrice Target and Rating Average Stock Price Target$22.33 High Stock Price Target$25.00 Low Stock Price Target$21.00 Potential Upside/Downside-8.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.23 billion Price / Sales1.26 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares63,294,000Free FloatN/AMarket Cap$1.54 billion OptionableN/A BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:GRDN) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.